The analysis found GLP-1 drugs slashed the risk of alcohol-related hospital admission by 26% compared with other diabetes medicines

Weight-loss jabs such as Wegovy and Mounjaro have been linked to a sharp decline in the number of people admitted to hospital for alcohol-use disorder.

The analysis found GLP-1 drugs slashed the risk of alcohol-related hospital admission by 26% compared with other diabetes medicines

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged…

The analysis found GLP-1 drugs slashed the risk of alcohol-related hospital admission by 26% compared with other diabetes medicines

The study looked at 50,000 people on the drugs

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged…

People on GLP-1 agonist drugs such as Mounjaro, Ozempic and Wegovy have been reporting hair loss